Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 122

1.

Caenorhabditis elegans As a Promising Alternative Model for Environmental Chemical Mixture Effect Assessment-A Comparative Study.

Wittkowski P, Marx-Stoelting P, Violet N, Fetz V, Schwarz F, Oelgeschläger M, Schönfelder G, Vogl S.

Environ Sci Technol. 2019 Nov 5;53(21):12725-12733. doi: 10.1021/acs.est.9b03266. Epub 2019 Oct 7.

PMID:
31536708
2.

Update of the DevTox data database for harmonized risk assessment and alternative methodologies in developmental toxicology: Report of the 9th Berlin Workshop on Developmental Toxicity.

Solecki R, Rauch M, Gall A, Buschmann J, Kellner R, Kucheryavenko O, Schmitt A, Delrue N, Li W, Hu J, Fujiwara M, Kuwagata M, Mantovani A, Makris SL, Paumgartten F, Schönfelder G, Schneider S, Vogl S, Kleinstreuer N, Schneider M, Schulze F, Fritsche E, Clark R, Shiota K, Chahoud I.

Reprod Toxicol. 2019 Oct;89:124-129. doi: 10.1016/j.reprotox.2019.07.003. Epub 2019 Jul 6.

PMID:
31288076
3.

Immediate occlusal vs nonocclusal loading of implants: A randomized prospective clinical pilot study and patient centered outcome after 36 months.

Vogl S, Stopper M, Hof M, Theisen K, Wegscheider WA, Lorenzoni M.

Clin Implant Dent Relat Res. 2019 Aug;21(4):766-774. doi: 10.1111/cid.12770. Epub 2019 May 7.

4.

Individualized prediction of the sound pressure at the eardrum for an earpiece with integrated receivers and microphones.

Vogl S, Blau M.

J Acoust Soc Am. 2019 Feb;145(2):917. doi: 10.1121/1.5089219.

PMID:
30823792
5.

Simple changes of individual studies can improve the reproducibility of the biomedical scientific process as a whole.

Steinfath M, Vogl S, Violet N, Schwarz F, Mielke H, Selhorst T, Greiner M, Schönfelder G.

PLoS One. 2018 Sep 12;13(9):e0202762. doi: 10.1371/journal.pone.0202762. eCollection 2018.

6.

Liver lobe and strain differences in the activity of murine cytochrome P450 enzymes.

Rudeck J, Bert B, Marx-Stoelting P, Schönfelder G, Vogl S.

Toxicology. 2018 Jul 1;404-405:76-85. doi: 10.1016/j.tox.2018.06.001. Epub 2018 Jun 4.

PMID:
29879457
7.

Outcomes of the Montana Asthma Home Visiting Program: A home-based asthma education program.

Fernandes JC, Biskupiak WW, Brokaw SM, Carpenedo D, Loveland KM, Tysk S, Vogl S.

J Asthma. 2019 Jan;56(1):104-110. doi: 10.1080/02770903.2018.1426766. Epub 2018 Feb 9.

PMID:
29425075
8.

Guarantee-Time Bias and Benefits of Surgery for Pleural Mesothelioma.

Vogl SE.

J Clin Oncol. 2018 Feb 20;36(6):624-625. doi: 10.1200/JCO.2017.75.9563. Epub 2018 Jan 5. No abstract available.

PMID:
29303626
9.

Thermalizing Sterile Neutrino Dark Matter.

Hansen RSL, Vogl S.

Phys Rev Lett. 2017 Dec 22;119(25):251305. doi: 10.1103/PhysRevLett.119.251305. Epub 2017 Dec 19.

PMID:
29303318
10.

Adjuvant ovarian suppression for resected breast cancer: 2017 critical assessment.

Vogl SE.

Breast Cancer Res Treat. 2017 Nov;166(1):1-13. doi: 10.1007/s10549-017-4379-1. Epub 2017 Jul 10. Review.

PMID:
28695299
11.

Carfilozomib versus bortezomib for relapsed or refractory myeloma.

Vogl SE.

Lancet Oncol. 2016 Apr;17(4):e125-e126. doi: 10.1016/S1470-2045(16)00083-8. Epub 2016 Mar 29. No abstract available.

PMID:
27300659
12.

Effect of Omeprazole and Dextromethorphan on the Urinary Metabolic Ratio of Flurbiprofen.

Vogl S, Steinfath M, Lutz WK, Schönfelder G.

Basic Clin Pharmacol Toxicol. 2016 Jun;118(6):496-8. doi: 10.1111/bcpt.12536. Epub 2016 Jan 14. No abstract available.

13.

Combination of intravenous S-ketamine and oral tranylcypromine in treatment-resistant depression: A report of two cases.

Bartova L, Vogl SE, Stamenkovic M, Praschak-Rieder N, Naderi-Heiden A, Kasper S, Willeit M.

Eur Neuropsychopharmacol. 2015 Nov;25(11):2183-4. doi: 10.1016/j.euroneuro.2015.07.021. Epub 2015 Aug 6.

PMID:
26302763
14.

Correction: CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.

Vogl S, Lutz RW, Schönfelder G, Lutz WK.

PLoS One. 2015 Apr 13;10(4):e0126329. doi: 10.1371/journal.pone.0126329. eCollection 2015. No abstract available.

15.

CYP2C9 genotype vs. metabolic phenotype for individual drug dosing--a correlation analysis using flurbiprofen as probe drug.

Vogl S, Lutz RW, Schönfelder G, Lutz WK.

PLoS One. 2015 Mar 16;10(3):e0120403. doi: 10.1371/journal.pone.0120403. eCollection 2015. Erratum in: PLoS One. 2015;10(4):e0126329.

16.

Does Timing of Implant Placement Affect Implant Therapy Outcome in the Aesthetic Zone? A Clinical, Radiological, Aesthetic, and Patient-Based Evaluation.

Hof M, Pommer B, Ambros H, Jesch P, Vogl S, Zechner W.

Clin Implant Dent Relat Res. 2015 Dec;17(6):1188-99. doi: 10.1111/cid.12212. Epub 2014 Feb 20.

PMID:
26010600
17.

Immediate Occlusal versus Non-Occlusal Loading of Implants: A Randomized Clinical Pilot Study.

Vogl S, Stopper M, Hof M, Wegscheider WA, Lorenzoni M.

Clin Implant Dent Relat Res. 2015 Jun;17(3):589-97. doi: 10.1111/cid.12157. Epub 2013 Sep 30.

PMID:
24118914
18.

[Sociodemographic aspects are associated with breast cancer screening behaviour of female patients: results of a cross-sectional survey].

Haluza D, Kundi M, Vogl S.

Gesundheitswesen. 2014 Sep;76(8-9):500-7. doi: 10.1055/s-0033-1349870. Epub 2013 Aug 2. German.

PMID:
23913396
19.

Ethnopharmacological in vitro studies on Austria's folk medicine--an unexplored lore in vitro anti-inflammatory activities of 71 Austrian traditional herbal drugs.

Vogl S, Picker P, Mihaly-Bison J, Fakhrudin N, Atanasov AG, Heiss EH, Wawrosch C, Reznicek G, Dirsch VM, Saukel J, Kopp B.

J Ethnopharmacol. 2013 Oct 7;149(3):750-71. doi: 10.1016/j.jep.2013.06.007. Epub 2013 Jun 13.

20.

Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.

Karle J, Bolbrinker J, Vogl S, Kreutz R, Denkert C, Eucker J, Wischnewsky M, Possinger K, Regierer AC.

Breast Cancer Res Treat. 2013 Jun;139(2):553-60. doi: 10.1007/s10549-013-2565-3. Epub 2013 May 18.

PMID:
23686417

Supplemental Content

Support Center